Vancomycin Dosing and Administration Guidelines

Standard Dosing for Adults with Normal Renal Function

The American College of Physicians and the Infectious Diseases Society of America recommend initial vancomycin dosing of 15-20 mg/kg (actual body weight) every 8-12 hours, not to exceed 2 g per dose, for adult patients with serious bacterial infections like MRSA 1, 2
For serious infections, such as bacteremia, endocarditis, osteomyelitis, meningitis, pneumonia, and necrotizing fasciitis, target trough concentrations of 15-20 μg/mL are recommended 1, 2
Weight-based dosing is particularly important in obese patients, who are likely to be underdosed with conventional dosing strategies of 1 g every 12 hours 1

A loading dose of 25-30 mg/kg (actual body weight) is recommended for seriously ill patients with suspected or documented MRSA infections, such as sepsis, meningitis, pneumonia, and endocarditis 1, 2
The Infectious Diseases Society of America found that a vancomycin loading dose of 25 mg/kg is safe in clinical studies 1

Trough vancomycin concentrations are the most accurate and practical method to guide vancomycin dosing, and should be obtained at steady state conditions, prior to the fourth or fifth dose 2
Trough monitoring is strongly recommended for serious infections and patients who are morbidly obese, have renal dysfunction, or have fluctuating volumes of distribution 1, 2

For children with serious or invasive disease, IV vancomycin 15 mg/kg/dose every 6 hours is recommended, with target trough concentrations of 15-20 μg/mL 1, 3

For patients with chronic kidney disease, dosing intervals should be adjusted according to the degree of renal dysfunction, as recommended by the National Kidney Foundation 4
For patients on hemodialysis, trough levels should be obtained immediately before the next scheduled hemodialysis session, as recommended by the National Kidney Foundation 4

The pharmacodynamic parameter that best predicts efficacy of vancomycin is the ratio of the area under the curve (AUC) to the MIC (AUC/MIC), with a target AUC/MIC ratio >400 associated with improved clinical response and microbiologic eradication 1, 2
For isolates with a vancomycin MIC >2 μg/mL, an alternative to vancomycin should be used, as target AUC/MIC ratios may not be achievable with conventional dosing 2

Underdosing vancomycin can lead to treatment failure and promote resistance development, while overdosing increases the risk of nephrotoxicity, especially when combined with other nephrotoxic agents 2
Vancomycin trough concentrations <10 μg/mL have been associated with treatment failures and development of resistance, as reported by the Centers for Disease Control and Prevention 1
Unnecessarily targeting high trough levels (15-20 μg/mL) for non-severe infections increases nephrotoxicity risk, as warned by the American College of Physicians 2

For patients with serious infections, the American Heart Association recommends target trough concentrations of 15-20 μg/mL, with alternative therapies considered if the vancomycin MIC is ≥2 μg/mL 5
The Infectious Diseases Society of America recommends target trough concentrations of 10-15 μg/mL for less severe infections, with consideration of antihistamine premedication and prolonged infusion time to minimize infusion-related reactions 6, 5
When administering vancomycin, especially in doses exceeding 1 gram, the infusion period should be extended to 1.5-2 hours to reduce the risk of red man syndrome, as suggested by the Clinical Infectious Diseases guidelines 5
Trough concentrations >20 μg/mL significantly increase nephrotoxicity risk, especially when combined with other nephrotoxic agents, according to the Clinical Infectious Diseases guidelines 5

For pediatric patients with complicated intra-abdominal infections, a dose of 40 mg/kg/day divided every 6-8 hours as a 1-hour infusion is recommended, with monitoring of antibiotic serum concentrations and renal function, as suggested by the Infectious Diseases Society of America 7
The American Academy of Pediatrics recommends monitoring trough concentrations before the fourth dose to guide dosing adjustments for complicated intra-abdominal infections, with a target trough concentration of 15-20 mg/L, according to the Clinical Infectious Diseases guideline 7

The Society of Critical Care Medicine suggests that critically ill children with normal renal function may require higher doses, with initial dosing of 60 mg/kg/day divided every 8 hours, although this is not directly cited, the principle of higher dosing in critically ill patients is supported by the need for therapeutic trough concentrations of 15-20 mg/L, as recommended for serious infections 7